Piperidinyl compounds

US7951804B2 · kind B2 · utility

Assignee

• Merck Patent GmbH · DE

Inventors

• Bertram Cezanne · Mörfelden, DE
• Dieter Dorsch · Ober-Ramstadt, DE
• Werner Mederski · Zwingenberg, DE
• Christos Tsaklakidis · Weinheim, DE
• Johannes Gleitz · Darmstadt, DE

Key dates

• Filing date: Nov 19, 2004
• Grant date: May 31, 2011
• Expiry date: Jul 2, 2027

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D487/08
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Novel compounds of the formula (I) in which D, E, Q, T, X, Y, Z, Z′, R1, R4 and R4′ have the meanings indicated, are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumors.